Epizyme (EPZM) Tops Q2 EPS by 7c

Epizyme (NASDAQ: EPZM) reported Q2 EPS of ($0.63), $0.07 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $736 thousand versus the consensus estimate of $2.45 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c